by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles Panelists discuss how to approach second-line therapy decisions for patients with metastatic breast cancer, emphasizing the importance of biomarker testing, including ESR1 mutations, and considering patient-specific factors. Read...
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support for young adults with cancer. Read More
by MM360 Staff | May 4, 2025 | Uncategorized
Source: CureToday articles Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the challenges these patients face. Read More
by MM360 Staff | May 4, 2025 | Uncategorized
Source: CureToday articles It is with great pride and admiration that I nominate Diane Hudson, RN, OCN, for the Extraordinary Healer Award for Oncology Nursing. Read More
by MM360 Staff | May 3, 2025 | Uncategorized
Source: CureToday articles Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic colorectal cancer. Read More
by MM360 Staff | May 3, 2025 | Uncategorized
Source: CureToday articles Post Content Read More
